Curcumin Inhibits the Development of Pancreatic Cancer by Targeting the circ_0079440/miR-522-3p/EIF4A1 Pathway
Cell Biochemistry and Biophysics · 2024
DOI: 10.1007/s12013-024-01466-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Ruiying Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, 730000, Gansu, China. Hauptthemen laut MEDLINE: Curcumin, RNA, Circular, Pancreatic Neoplasms, MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Cuiying Doctoral Supervisor Training Program.
Abstract (Originalsprache)
Pancreatic cancer (PC) is a common gastrointestinal cancer with high invasiveness and high mortality. Curcumin is a natural polyphenol with anti-tumor activity against different cancers, including PC. Curcumin has been verified to mediate the expression of circular RNAs (circRNAs) to inhibit tumor development. This study aimed to explore the function and regulatory mechanism of curcumin on circ_0079440 in PC. PC cells were treated with different concentrations of curcumin (0, 5, 10 or 15 μM) for 24 h. Gene expression in PC cells and tissues was detected using RT-qPCR. Cell malignant phenotypes were determined by functional assays. The levels of EMT-related proteins were tested using western blot. RNA interaction was determined using RNA pulldown assay, luciferase reporter assay and RIP assay. The results showed that curcumin suppressed cell proliferative, migratory, and invasive capabilities, and weakened epithelial-mesenchymal transition (EMT) in a concentration-dependent way. Circ_0079440 was expressed at a high level in PC and its level was reduced via curcumin administration in PC cells. Rescue assays showed that circ_0079440 overexpression reversed the suppressive effects of curcumin on PC cell malignant phenotypes. Furthermore, in the xenograft mouse models, curcumin treatment inhibited tumor growth and metastasis, and circ_0079440 upregulation reversed the function of curcumin. Additionally, circ_0079440 was revealed to bind to miR-522-3p to upregulate eukaryotic initiation factor 4A1 (EIF4A1) expression in PC cells. EIF4A1 expression was also downregulated by curcumin, and EIF4A1 overexpression abolished the suppressive functions of curcumin. Moreover, EIF4A overexpression or miR-522-3p inhibition counteracted the anti-tumor effects of circ_0079440 depletion on PC development. To sum up, curcumin suppresses PC development by targeting the circ_0079440/miR-522-3p/EIF4A1 pathway, which might provide novel therapeutic targets for treatment of PC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, 730000, Gansu, China.
- Department of respiratory medicine, The Third People's Hospital of Gansu Province, Lanzhou, 730000, Gansu, China.
- Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, 730000, Gansu, China. luocj2021@163.com.
Förderung
- Cuiying Doctoral Supervisor Training Program
Zitieren
APA
Luo, R., Li, S., Yang, C., Tang, B., Li, L., & Luo, C. (2024). Curcumin Inhibits the Development of Pancreatic Cancer by Targeting the circ_0079440/miR-522-3p/EIF4A1 Pathway. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01466-8
Vancouver
Luo R, Li S, Yang C, Tang B, Li L, Luo C. Curcumin Inhibits the Development of Pancreatic Cancer by Targeting the circ_0079440/miR-522-3p/EIF4A1 Pathway. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01466-8
BibTeX
@article{Luo2024,
author = {Luo, Ruiying and Li, Shuang and Yang, Chi and Tang, Baoyuan and Li, Long and Luo, Changjiang},
title = {Curcumin Inhibits the Development of Pancreatic Cancer by Targeting the circ_0079440/miR-522-3p/EIF4A1 Pathway},
journal = {Cell Biochemistry and Biophysics},
year = {2024},
doi = {10.1007/s12013-024-01466-8}
}
EUVIMED